A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
12/2004
12/21/2004	US6833140 Orally administered dosage forms of GABA analog prodrugs having reduced toxicity
12/21/2004	US6833130 Recombinant microorganisms expressing an oligosaccharide receptor mimic
12/21/2004	CA2317604C Matrix metalloprotease inhibitors
12/16/2004	WO2004108907A1 Nerve cell obtained by electrically pulse-treating es cell
12/16/2004	WO2004108714A1 Cycloalkylsulfanyl substituted benzo[b]thiophenes as therapeutic agents
12/16/2004	WO2004108160A1 Osteogenesis-promotion enhancer and method of screening the same
12/16/2004	WO2004108131A1 Compounds inhibiting the binding of sap for treating osteoarthritis
12/16/2004	WO2004064832A3 Methods for treating joint pain or improving sleep using an estrogen agonist/antagonist
12/16/2004	WO2004035740A3 Aromatic bicyclic heterocyles to modulate 1l - 12 production
12/16/2004	WO2004010951A3 Method of treating tumors
12/16/2004	WO2003066666A3 Compositions and methods for treatment of vitamin d deficiency
12/16/2004	US20040254382 Imidazolyl derivatives as corticotropin releasing factor inhibitors
12/16/2004	US20040254378 2-Methanesulfone group; Side effect reduction; Nonsteroidal Antiinflammatory
12/16/2004	US20040254376 Cyclic amidine derivative
12/16/2004	US20040254362 Nucleotide sequences coding polypeptide associate with fatty acid metabolism for use in diagnosis, prevention and treatment of obesity, diabetes and heart disease
12/16/2004	US20040254350 Immunomodulatory protein for use in diagnosis, treatment, and prevention of immune system, neurological, developmental, muscle and cell proliferative disorders
12/16/2004	US20040254249 Nonsteroidal antiinflammatory agents
12/16/2004	US20040254233 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors
12/16/2004	US20040254216 Inhibitors of p38
12/16/2004	US20040254212 Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors
12/16/2004	US20040254211 Alpha v integrin receptor antagonists
12/16/2004	US20040254210 Pharmaceutical compositions comprising colloidal silicon dioxide
12/16/2004	US20040254203 Methods and compositions utilizing quinazolinones
12/16/2004	US20040254200 Antiinflammatory agents; controlling interleukins, tumor necrosis factor; antiarthritic agents; immunosuppressants
12/16/2004	US20040254198 Respiratory system disorders; asthma; chronic obstructive pulmonary disease
12/16/2004	US20040254192 2,4,5-trisubstituded thiazolyl derivatives and their antiinflammatory activity
12/16/2004	US20040254189 Jnk inhibitors
12/16/2004	US20040254177 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
12/16/2004	US20040254151 Osteoporosis, bone cancer; antiarthritic agents;paget's disease; antiinflammatory agents
12/16/2004	US20040254149 Antiproliferative agents; antiinflammatory agents; anticancer agents; diagnosis, therapy
12/16/2004	US20040254145 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries
12/16/2004	US20040254128 Treatment and prevention of heat shock protein-associated diseases and conditions
12/16/2004	US20040254102 Remedies for bone diseases
12/16/2004	US20040253709 Schistosoma protein for use in treatment of organ-specific autoimmune diseases
12/16/2004	US20040253588 Cytochrome p450 monooxygenase for use in identifying modulators for treatment, diagnosis and prevention of autoimmune/inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, gastrointestinal and liver disorders
12/16/2004	US20040253276 Oil-in-water emulsion of a 1-carboxylate-6-arylsulfamoyl cyclohexene and synthetic and naturally occurring phospholipids; nitric oxide or cytokine prodution inhibitors; cardiovascular disorders, autoimmune dieseases, septic shock; improved stability during autoclave sterilization
12/16/2004	US20040253245 Modulating an immune response by administering a modulator of Notch intracellular domain protease activity, including modulators of presenilin and presenilin-dependent gamma secretase activity; immunotherapy; treatment of Alzheimer's disease
12/16/2004	US20040253231 monoclonal or polyclonal antibodies having specific reactivity with adenosine triphosphate binding domains, caspase recruitment domains and triosephosphate isomerase domain peptides, used for modulation of apoptosis
12/16/2004	CA2527984A1 Vascular endothelial growth factor fusion constructs and uses thereof
12/16/2004	CA2527341A1 Cycloalkylsulfanyl substituted benzo[b]thiophenes as therapeutic agents
12/15/2004	EP1486496A1 Substituted 2-(2,6-Dioxopiperidin-3-YP)-Phthalimides and 1-Oxoisoindolines and method fo reducing TNF alpha levels
12/15/2004	EP1486486A2 Substituted B-thiocarboxylic acids
12/15/2004	EP1486214A1 Botulinum toxins for treating muscle spasm
12/15/2004	EP1486207A2 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
12/15/2004	EP1485468A2 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
12/15/2004	EP1485394A1 Process for isolation of eupalitin (3-o-beta-d-galactopyranoside) from boerhavia diffusa
12/15/2004	EP1485391A2 Phosphate transport inhibitors
12/15/2004	EP1485390A1 Bicyclic pyridine and pyrimidine p38 kinase inhibitors
12/15/2004	EP1485384A1 Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators
12/15/2004	EP1485381A1 Azolylaminoazine as inhibitors of protein kinases
12/15/2004	EP1485380A1 Azolylaminoazines as inhibitors of protein kinases
12/15/2004	EP1485375A1 Pyrimidine compounds
12/15/2004	EP1485374A1 Pyrimidine compounds
12/15/2004	EP1485370A1 Amino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485364A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485354A1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485353A1 New inhibitors of histone deacetylase
12/15/2004	EP1485132A2 Combination of an aldosterone receptor antagonist and a fibric acid derivative
12/15/2004	EP1485119A1 Enhancing the availability of minerals by using biologically active peptides
12/15/2004	EP1485113A1 Water soluble bioactive fraction isolated from gum resin exudate of boswellia serrata, process for isolation thereof, composition containing said fraction and use thereof
12/15/2004	EP1485105A1 Combination of an aldosterone receptor antagonist and a bile acid sequestering agent
12/15/2004	EP1485104A1 Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative
12/15/2004	EP1485100A1 Azinylaminoazoles as inhibitors of protein kinases
12/15/2004	EP1485099A1 Inhibitors of histone deacetylase
12/15/2004	EP1485095A1 Fluorinated 4-azasteroid derivatives as androgen receptor modulators
12/15/2004	EP1485092A1 Use of rapamycin for inhibiting of cell death
12/15/2004	EP1485089A1 Combination treatments for chemokine-mediated diseases
12/15/2004	EP1485088A1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds
12/15/2004	EP1485087A1 (+)-2- 1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
12/15/2004	EP1485083A2 Dexanabinol and dexanabinol analogs regulate inflammation related genes
12/15/2004	EP1485073A2 Method for administration of growth hormone via pulmonary delivery
12/15/2004	EP1485072A1 Hormone-containing transdermal therapeutic system with an active substance reservoir based on vinylacetate-vinylpyrrolidone copolymer with improved cohesion.
12/15/2004	EP1485068A2 hGH (HUMAN GROWTH HORMONE) FORMULATIONS FOR PULMONARY ADMINISTRATION
12/15/2004	EP1436285A4 Processes for the preparation of 1,5-diaryl-3-substituted-pyrazoles
12/15/2004	EP1401862A4 Peptide compounds for counteracting reactive oxygen species and free radicals
12/15/2004	EP1399155A4 Small molecules useful in the treatment of inflammatory disease
12/15/2004	EP1263711B1 Novel use of phenylheteroalkylamine derivatives
12/15/2004	EP1226160B1 Novel antiarrhythmic peptides
12/15/2004	EP1226137B8 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity
12/15/2004	EP1218005B1 Vitronectin receptor antagonists
12/15/2004	EP1175222B1 Monthly doses of glycopeptide antibiotics for long-term prevention of streptococcus pneumoniae infections
12/15/2004	EP1128838A4 A method of inducing or enhancing chondrogenesis with extracellular matrix containing gdf-5
12/15/2004	EP1068180B1 Process for alkylating hindered sulfonamides useful in the production of matrix metalloprotenase inhibitors
12/15/2004	EP0929270B1 Oral peptide pharmaceutical products
12/15/2004	CN1555379A Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
12/15/2004	CN1555375A Compounds for inhibiting the release of inflammatory cytokines
12/15/2004	CN1555374A Novel pyridine-substituted pyrazolopyridine derivatives
12/15/2004	CN1555351A Method for the preparation of unsaturated hydroxy fatty acids and their esters, their use in pharmaceutical and/or cosmetic preparations
12/15/2004	CN1555272A Compositions and methods for modulation of immune responses
12/15/2004	CN1555268A Therapeutic agents comprising pro-apoptotic proteins
12/15/2004	CN1555266A Hormone replacement therapy
12/15/2004	CN1554416A Chinese medicine decoction recipe fortreating prolapse of lumber intercertebtral disc
12/15/2004	CN1554404A Recovery paste for osteonosus
12/15/2004	CN1554398A Medicine for treating protrusion of lumber intervertevral disc
12/15/2004	CN1554395A Chinese medicinal composition for treating rheumatoid arthritis
12/15/2004	CN1554383A Composition for treating osteoporosis
12/15/2004	CN1554380A Massage liquid for treating hyperosteogeny and protrusion of lumbar intervertebral disc and its preparing method
12/15/2004	CN1554374A Method for producing hyperplasia and traumatic injury paste
12/15/2004	CN1554372A External use medicine for hemostatic and trauma healing and promoting reunion of fractured bones
12/15/2004	CN1554369A Medicine for treating rheumatoid arthritis and its preparing method

1 ... 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 ... 820